Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s47, 2021. DOI: 10.25251/skin.5.supp.47. Disponível em: https://skin.dermsquared.com/skin/article/view/1398. Acesso em: 13 oct. 2025.